Stay updated on Amcenestrant in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Amcenestrant in ER+ Breast Cancer Clinical Trial page.

Latest updates to the Amcenestrant in ER+ Breast Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page no longer displays the 403 error or the NIH transition announcement, and the “Study Record,” “Search Results,” and “Home” labels are absent.SummaryDifference2%

- Check8 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.2 to v3.8.0 while the page continued to show a 403 error.SummaryDifference0.2%

- Check15 days agoChange DetectedA banner was added announcing NIH website changes and explaining that some NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check22 days agoChange DetectedThe revision identifier in the footer changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1 while the 403 error page remained otherwise unchanged.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the full study content, blocking viewing of the records and documents. A minimal 403 page with a Home link and a Revision banner replaces the former detailed study information and attachments.SummaryDifference23%

Stay in the know with updates to Amcenestrant in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amcenestrant in ER+ Breast Cancer Clinical Trial page.